An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

NCT07033026 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
CRC (Colorectal Cancer)
Cancer Cachexia

Interventions

DRUG: NGM120 Q4W
DRUG: NGM120 Q8W
DRUG: Placebo given

Sponsor

NGM Biopharmaceuticals, Inc